"Designing Growth Strategies is in our DNA"

Sickle Cell Disease Treatment Market to Grow at a CAGR of 20.1% over 2023-2030; Increasing Prevalence of Sickle Cell Disorders to Fuel Industry Growth

 

Speak to Analyst

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X